Emory Alzheimer's Disease Research Center

埃默里阿尔茨海默病研究中心

• 批准号: 10408030
• 负责人: DAVID WEINSHENKER
• 金额: $ 15.69万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-15 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10408030
• 关键词: Achievement; Address; Advisory Committees; Affect; Alzheimer' s Disease; Alzheimer' s disease related dementia; Alzheimer' s disease therapeutic; American; Area; Behavioral; Biomedical Engineering; Catalogs; Clinical; Clinical Research; Clinical Sciences; Companions; Complement; Data Science; Dementia; Diagnostic; Discipline; Education; Educational Activities; Educational Curriculum; Educational workshop; Environment; Evaluation; Faculty; Fostering; Funding; Future; Generations; Goals; Institution; Laboratories; Lead; Leadership; Mentors; Mentorship; Methodology; Minority; Mission; Molecular; Monitor; Neurosciences; Output; Participant; Pathogenicity; Postdoctoral Fellow; Prevalence; Prevention; Recording of previous events; Research; Research Activity; Research Personnel; Research Support; Research Training; Resources; Scientist; Standardization; System; Teacher Professional Development; Time; Training; Training Programs; Translational Research; Translations; Underrepresented Minority; Universities; Work; career; cohort; education research; education resources; experience; innovation; instrument; meetings; minority investigator; minority trainee; multidisciplinary; next generation; programs; recruit; skills; success; symposium; targeted biomarker; therapeutic target; tool; translational scientist

SUMMARY/ABSTRACT: RESEARCH EDUCATION COMPONENT Alzheimer’s disease (AD) is the most common cause of dementia, affecting more than 5 million Americans. At the same time that the prevalence of AD is increasing, the number of new investigators in the US is decreasing, which may severely hamper our efforts to develop better diagnostic and treatment tools for AD and related dementias (ADRD). The goal of the Research Education Component (REC) of the Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory is to support research educational activities that complement and enhance the training of the future workforce to meet the nation’s biomedical, behavioral and clinical needs in ADRD. We will achieve this goal by identifying and supporting the research education of junior investigators and trainees from diverse backgrounds and disciplines. In Aim 1, REC leadership and mentors will work with these trainees to develop and execute tailored educational plans for new and early stage investigators to advance towards independence in conducting AD-related research. In Aim 2, we will leverage Emory’s wealth of basic and clinical scientists as well as partner Atlanta-area institutions to identify, recruit and support the research training of new/early stage investigators and trainees from diverse backgrounds and disciplines, with special emphasis on URMs, to engage in AD-related research. In Aim 3, the REC leadership and external advisory committee will rigorously monitor and evaluate the trainees, mentors, and the overall program, and implement improvements when necessary. Success of the REC will result in rolling cohorts of new investigators with a focus on diversity to lead the next generation of ADRD research.

摘要/摘要：研究教育组成部分 阿尔茨海默病(AD)是导致痴呆症的最常见原因，影响着500多万美国人。在… 在AD患病率上升的同时，美国新的调查人员数量 减少，这可能严重阻碍我们努力开发更好的AD和 相关痴呆(ADRD)。Goizueta的研究教育部分(REC)的目标 埃默里阿尔茨海默氏症研究中心(ADRC)将支持以下研究教育活动 补充和加强对未来劳动力的培训，以满足国家的生物医学、行为和 ADRD的临床需求。我们将通过确定和支持初中学生的研究性教育来实现这一目标 来自不同背景和学科的调查人员和受训人员。在目标1中，REC领导力和导师 将与这些学员合作，为新的和早期阶段制定和执行量身定做的教育计划 调查人员在进行AD相关研究方面走向独立。在目标2中，我们将利用 埃默里拥有丰富的基础和临床科学家以及亚特兰大地区的合作机构，以识别、招聘和 支持对来自不同背景的新/早期调查人员和受训人员进行研究培训，并 各学科，特别是URM，从事AD相关研究。在Aim 3中，REC领导层 和外部咨询委员会将严格监督和评估学员、导师和整体 计划，并在必要时实施改进。区域经济共同体的成功将导致一批 专注于多样性的新研究人员将领导下一代ADRD研究。